The future of medication abortions across the U.S.—even in states with few abortion restrictions—is on the line. Experts call a recent, soon-to-be-decided lawsuit the most consequential court case for nationwide abortion access since the overturning of Roe v. Wade.

A ruling is expected as soon as Feb. 24. Here’s what to know about the case.

What the lawsuit says

The suit, filed Nov. 18, 2022 on behalf of the anti-abortion physician’s group Alliance for Hippocratic Medicine (AHM), seeks to overturn the U.S. Food and Drug Administration (FDA)’s approval of mifepristone: one of the two prescription pills that are typically used in combination to terminate pregnancies, and which account for more than half of all U.S. abortions. AHM …